Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation | Zendy

Gerald V. Naccarelli | Zendy; W. Frank Peacock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation

Author(s) -

Gerald V. Naccarelli,

W. Frank Peacock

Publication year - 2009

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s7616

Subject(s) - medicine , atrial fibrillation , cardiology , heart failure , angiotensin receptor blockers , stroke (engine) , cardiac arrhythmia , renin–angiotensin system , angiotensin ii , receptor , blood pressure , mechanical engineering , engineering

Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research